← All studies

1994 · McGown — Regeneration of Functional Hemoglobin from Partially Oxidized Hemoglobin in the Presence of Molecular Hydrogen and a Multicomponent Redox Catalyst

Original title: Regeneration of functional hemoglobin from partially oxidized hemoglobin in the presence of molecular hydrogen and a multicomponent redox catalyst.

Super-Abstract

This in-vitro study demonstrated that molecular hydrogen (H₂) can reduce partially oxidized (met-)hemoglobin back to functional hemoglobin when a multicomponent redox catalyst is present — a proof-of-concept for H₂ as a biochemical reducing agent. No abstract is publicly available in the database record; details are accessible via the original publication. (Methods in Enzymology, 1994.)

Classified as a Mechanism / Preclinical study using Unspecified. See Methodology for how we grade evidence.

Commentary

This work by McGown and colleagues is a biochemical proof-of-concept study: using H₂ gas and a catalyst system to chemically reduce methemoglobin (oxidized, non-functional hemoglobin) back to functional oxyhemoglobin. The connection to hydrogen medicine lies in H₂'s capacity as a selective reducing agent — a theme also central to its antioxidant action in cells. However, this is a purely in-vitro biochemical study using a multicomponent redox catalyst; it does not represent physiological conditions, and no conclusions about therapeutic H₂ administration in humans can be drawn from this paper alone. No abstract is available in the database entry.

Key quotes

  1. „Regeneration of functional hemoglobin from partially oxidized hemoglobin in the presence of molecular hydrogen and a multicomponent redox catalyst.“ — title only — no abstract available; the core finding is stated in the title

Our assessment

This is an in-vitro biochemistry study demonstrating H₂ as a reducing agent for methemoglobin — not a therapeutic study. It is mechanistically interesting as an early demonstration of H₂ reactivity in biological molecules, but cannot serve as clinical evidence for therapeutic H₂. The use of an external multicomponent redox catalyst means the conditions are far from physiological. No abstract is available; a complete evaluation requires access to the original publication in Methods in Enzymology (1994).

Study design

Source & links

Screenshot of the PubMed page

Screenshot — PubMed 8041275

This page mirrors the published abstract (© the authors / publisher) for reference and citation. The canonical source is the PubMed record linked above. This is not medical advice.